Clinical trial
The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
NCT06707025 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 10, 2023
- Completion date
- October 28, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.